Nutrition, Motion, Go – Physical exercise programme Nutrition Motion Go Physical Exercise Programme

Föreläsning av Maria Rehbinder, leg. dietist Maria har en gedigen erfarenhet av att arbeta med kostbehandling till patienter som har diabetes. Under föreläsningen delar Maria med sig av vad som är viktigt att tänka på när man har en patient som har undernäring och samtidig diabetes framför sig, och vad det är som man ofta missar att tänka på. Maria ger dessutom ge konkreta råd och förslag kring kostbehandlingen, och delar med sig av hur hon tänker kring energi- och proteinbehov, kolhydratintag, fördelning av makronutrienter, berikning av mat, och vad som är viktigt att ta hänsyn till vid val av näringsdryck.

In the webinar, the important role of protein and protein quality in the nutritional treatment will be highlighted. Professor Philipp Schuetz will talk about the importance of malnutrition management and individualized nutritional support to improve patients’ outcome. Additionally, Ola Wallengren will give insights on what role protein and protein quality have in the nutritional treatment, along with current protein recommendations and strategies to meet them.

High-quality milk protein contains high levels of essential branched chain amino acids. The branched chain amino acid leucine is particularly a potent stimulator of muscle protein synthesis. This video shows you the mechanism of how leucine stimulates the muscle protein synthesis. 

This toolkit has been specially designed to ease the work of healthcare professionals during functional and nutritional assessment of their patients with mobility impairment and (risk of) malnutrition. It contains fully validated and internationally recognized screening and diagnosis tools most often used in clinical practice. The aim is to support healthcare professionals with tools to early detect frailty, sarcopenia and malnutrition to ensure timely intervention.

During the webinar, we will place great emphasis on the importance of protein and protein quality in nutritional treatment. We are happy to have Dr. Martin Hagve, PhD, Chief physician and Specialist in Gastroenterological Surgery, University Hospital of North-Norway, Associate Professor at UiT - The Arctic University of Norway, as lecturer. During the presentation, Dr. Martin will go through existing guidelines and share his experience from everyday clinical practice and how to best reach the patients’ protein targets. The webinar is held in English.

In this brochure, we have collected some of the new and relevant references highlighting the importance of improving the nutritional status among patients, or geriatric individuals, with or at risk of disease-related malnutrition. This brochure includes guidelines for protein and energy requirements, as well as study summaries on the importance of protein quality to regain and build muscle mass. In particular, studies on leucine are included, since this is the most potent amino acid to stimulate muscle protein synthesis. Leucine has been proposed to have a beneficial effect on muscle mass, muscle strength and physical function.

Mobility impairment is characterized by loss of muscle mass, bone mass and function, and may be caused by age-related diseases (e.g. sarcopenia or frailty), acute accidental events (e.g. falls and fractures) and mobility-induced chronic diseases (e.g. osteoarthritis). Nutritional management of malnutrition and mobility impairment typically focus on dietary guidance and may include treatment with oral nutritional supplements (ONS) to provide a high calorie and protein-rich diet of good protein quality.  This study summary gives an overview of some key clinical studies on the composition of oral nutrition supplement for the nutritional management of malnutrition and impaired mobility.

With age, we gradually begin to lose muscle mass, bone mass and strength. Sarcopenia is a serious condition which becomes more common with age and is characterized by a progressive loss of skeletal muscle mass and strength, which results in functional decline and is associated with an increased risk of adverse health outcomes.